It is going to take a lot for someone to wrestle that away from them, at least in the near future. And as for amylin analogs, Papamargaritis, the Leicester researcher, says that, based on current data, Lillys molecule is leading in terms of the amount of weight loss it can offer, but that doesnt mean the market doesnt have a place for other amylin analogs as well as drugs that target other receptors, such as glucagon
Most supplements are overloaded with artificial ingredients that disrupt digestion, leave you feeling bloated, or coat your palate with a chemical aftertaste
(2024): Glucagon-like peptide-1 receptor: mechanisms and advances in therapy
Functional nutrition brands are increasingly running usage and attitude studies, claims testing, and product format research to identify which delivery formats work best for appetite-suppressed consumers because the future of nutrition may depend not on flavor alone, but on convenience, digestibility, and perceived efficacy
